Χρόνια νεφρική νόσος και αιμοκάθαρση. Ποιότητα ζωής και κόστος θεραπείας
Chronic kidney disease and dialysis. Quality of life and cost treatment
View/ Open
Keywords
Ποιότητα ζωής ; Χρόνια νεφρική νόσος ; Προθυμία πληρωμήςAbstract
Chronic kidney disease (CKD) affects a significant proportion of the world population and millions die every year because they have no access to affordable treatment. CKD's global cost has quadrupled in the past 20 years and is expected to continue to increase due to global population growth and aging. The purpose of this research will be to record the quality of life of patients with chronic renal disease undergoing hemodialysis, transplant patients and NDD-CKD patients (chronic renal disease not dependent on hemodialysis), recording of treatment costs based on EOPPY and the recording of willingness-to-pay with the ultimate goal of improving quality of life. For this purpose, a quantitative survey was performed using a questionnaire in a sample of 58 patients (8 transplant patients, 35 hemodialysis patients and 15 NDD-CKD patients). If we consider that every year a patient is dialyzing about 2 times a week, then the cost per patient for the insurance funds per year was estimated at 13053.6 euros. The analysis of the data showed that the dialysis group had a worse quality of life than the transplant group and the NDD-CKD patient population. The results of the assessment of the cost of healthcare that patients are forced to pay on their own money (not covered by EOPPY) on a weekly basis showed that the hemodialysis group had a higher average cost than the group of patients both transplantation and NDD-CKD patients. The results showed that the hemodialysis group showed greater willingness to pay to have a 50% improvement in their quality of life compared to the transplant patients and the NDD- CKD. Finally, the analysis of whether the quality of life is related to cost and willingness to pay. In conclusion, we can conclude that hemodialysis patients have a reduced quality of life compared to transplant patients and patients who are not dependent on hemodialysis. In addition, quality of life seems to be related to patients' cost and willingness to pay to ensure a better quality of life.